Order Article Reprints

Kim T-Y, Park S, Kwag D, Lee J-H, Lee J, Min G-J, Park S-S, Jeon Y-W, Shin S-H, Yahng S-A, et al. Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification. Cancers. 2022; 14(13):3199. https://doi.org/10.3390/cancers14133199

Kim, Tong-Yoon, Silvia Park, Daehun Kwag, Jong-Hyuk Lee, Joonyeop Lee, Gi-June Min, Sung-Soo Park, Young-Woo Jeon, Seung-Hawn Shin, Seung-Ah Yahng, and et al. 2022. "Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification" Cancers 14, no. 13: 3199. https://doi.org/10.3390/cancers14133199

Kim, T.-Y., Park, S., Kwag, D., Lee, J.-H., Lee, J., Min, G.-J., Park, S.-S., Jeon, Y.-W., Shin, S.-H., Yahng, S.-A., Yoon, J.-H., Lee, S.-E., Cho, B.-S., Eom, K.-S., Kim, Y.-J., Lee, S., Min, C.-K., Cho, S.-G., Lee, J.-W., & Kim, H.-J. (2022). Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification. Cancers, 14(13), 3199. https://doi.org/10.3390/cancers14133199